EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical and radiologic distinctions between familial cavernous malformation syndrome and cerebral amyloid angiopathy

K D Flemming, Jonathan Graff Radford, Ross Reichard, James Klaas, Sherri Braksick, Petrice Cogswell, Giuseppe Lanzino

Acta Neurochirurgica · 2024

DOI: 10.1007/s00701-024-06400-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neurochirurgica, 2024. Verfasst von K D Flemming und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Flemming.Kelly@mayo.edu. Hauptthemen laut MEDLINE: Hemangioma, Cavernous, Central Nervous System, Cerebral Amyloid Angiopathy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NIH and the GHR foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Familial cerebral cavernous malformation syndrome (FCCM) is characterized by multiple hemorrhagic lesions and is sometimes mistaken for cerebral amyloid angiopathy (CAA). METHODS: We compared clinical and radiologic characteristics in patients with definite (N = 32) and presumed FCCM (n = 76) to patients with definite (N = 29) and probable CAA (N = 21). RESULTS: Patients with CAA were older (78.6 years CAA vs. 43.4 FCCM; p < 0.0001), had cognitive complaints (66.0% CAA vs. 8.3% FCCM; p < 0.0001), and less likely to have a family history (4.0% CAA vs. 50.9% FCCM; p < 0.0001). FCCM patients were more likely to have at least 1 Zabramski type 2 lesion (0 CAA vs. 79.6% FCCM; p < 0.0001). Presence of any subcortical white matter hemorrhagic lesion (23.0% CAA vs. 99.1% FCCM; p < 0.0001), a lesion in either the basal ganglia, internal capsule or cerebellum (28.0% CAA vs 79.6% FCCM; p < 0.0001) and a subcortical white matter to cortical ribbon distribution of hemorrhagic lesions ≥ 1.0 was predictive of FCCM (6.0% CAA vs 83.9% FCCM; p < 0.0001). CAA patients more commonly had white matter disease, sulcal subarachnoid hemorrhage, and severely enlarged perivascular spaces in the centrum. However, none of the latter features were unique to CAA. FCCM patients meeting Boston 2.0 criteria for CAA (n = 14) had additional factors that helped distinguish them from CAA. CONCLUSIONS: Patients with FCCM can be reliably distinguished from CAA by accurately applying the Boston 2.0 criteria, assessing hemorrhagic lesion distribution and types, and assessing for clinical features unique to FCCM. FCCM criteria are proposed. The frequent finding of leukoaraiosis and enlarged perivascular spaces in the centrum semiovale in FCCM patients deserves further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemangioma, Cavernous, Central Nervous SystemCerebral Amyloid AngiopathyHumansMaleFemaleAgedMiddle AgedAdultAged, 80 and overDiagnosis, DifferentialMagnetic Resonance Imaging

Stichwörter der Autor:innen

Cavernous malformationCerebral amyloid angiopathyEnlarged perivascular spaceLeukoaraiosisMRI

Autor:innen und Institutionen

  • Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Flemming.Kelly@mayo.edu.
  • Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
  • Department of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA.
  • Department of Neuroradiology, Mayo Clinic, Rochester, MN, USA.
  • Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA.

Förderung

  • NIA NIH HHS
  • NIH and the GHR foundation

Zitieren

APA

Flemming, K. D., Radford, J. G., Reichard, R., Klaas, J., Braksick, S., Cogswell, P., & Lanzino, G. (2024). Clinical and radiologic distinctions between familial cavernous malformation syndrome and cerebral amyloid angiopathy. Acta Neurochirurgica. https://doi.org/10.1007/s00701-024-06400-8

Vancouver

Flemming KD, Radford JG, Reichard R, Klaas J, Braksick S, Cogswell P, et al. Clinical and radiologic distinctions between familial cavernous malformation syndrome and cerebral amyloid angiopathy. Acta Neurochirurgica. 2024. doi:10.1007/s00701-024-06400-8

BibTeX
@article{Flemming2024,
  author = {Flemming, K D and Radford, Jonathan Graff and Reichard, Ross and Klaas, James and Braksick, Sherri and Cogswell, Petrice and Lanzino, Giuseppe},
  title = {Clinical and radiologic distinctions between familial cavernous malformation syndrome and cerebral amyloid angiopathy},
  journal = {Acta Neurochirurgica},
  year = {2024},
  doi = {10.1007/s00701-024-06400-8}
}
Kostenlos starten →